Cargando…

Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could prompt various neurological complications. Abrupt visual disturbance was reported as a rare severe manifestation of post-coronavirus disease 2019 (COVID-19). Autoimmune conditions were assumed to have an undeniable role in creation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Motahharynia, Ali, Naghavi, Saba, Shaygannejad, Vahid, Adibi, Iman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212982/
https://www.ncbi.nlm.nih.gov/pubmed/35757456
http://dx.doi.org/10.1016/j.ensci.2022.100411
_version_ 1784730736233807872
author Motahharynia, Ali
Naghavi, Saba
Shaygannejad, Vahid
Adibi, Iman
author_facet Motahharynia, Ali
Naghavi, Saba
Shaygannejad, Vahid
Adibi, Iman
author_sort Motahharynia, Ali
collection PubMed
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could prompt various neurological complications. Abrupt visual disturbance was reported as a rare severe manifestation of post-coronavirus disease 2019 (COVID-19). Autoimmune conditions were assumed to have an undeniable role in creation of such circumstances. This report presents a 69-year-old woman with sudden bilateral blindness three weeks after recovering from a SARS-CoV-2 infection. Demyelination due to COVID-19-related autoimmune disorder of the central nervous system (CRAD-C) was considered to be the etiology of her bilateral blindness. Due to her progressive demyelination, immunosuppressive treatments were administered, which resulted in stabilizing post-COVID-19 demyelinating lesions. Accordingly, in the case of COVID-19-related neurological deficits, especially the acute and progressive symptoms, there should be great consideration of autoimmune response to prevent serious complications; hence early diagnosis, treatment, and long-term assessment of patients are necessitated.
format Online
Article
Text
id pubmed-9212982
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92129822022-06-22 Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19 Motahharynia, Ali Naghavi, Saba Shaygannejad, Vahid Adibi, Iman eNeurologicalSci Case Report Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could prompt various neurological complications. Abrupt visual disturbance was reported as a rare severe manifestation of post-coronavirus disease 2019 (COVID-19). Autoimmune conditions were assumed to have an undeniable role in creation of such circumstances. This report presents a 69-year-old woman with sudden bilateral blindness three weeks after recovering from a SARS-CoV-2 infection. Demyelination due to COVID-19-related autoimmune disorder of the central nervous system (CRAD-C) was considered to be the etiology of her bilateral blindness. Due to her progressive demyelination, immunosuppressive treatments were administered, which resulted in stabilizing post-COVID-19 demyelinating lesions. Accordingly, in the case of COVID-19-related neurological deficits, especially the acute and progressive symptoms, there should be great consideration of autoimmune response to prevent serious complications; hence early diagnosis, treatment, and long-term assessment of patients are necessitated. Elsevier 2022-06-16 /pmc/articles/PMC9212982/ /pubmed/35757456 http://dx.doi.org/10.1016/j.ensci.2022.100411 Text en © 2022 Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Motahharynia, Ali
Naghavi, Saba
Shaygannejad, Vahid
Adibi, Iman
Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19
title Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19
title_full Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19
title_fullStr Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19
title_full_unstemmed Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19
title_short Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19
title_sort abrupt bilateral blindness as a rare post-acute demyelinating consequence of covid-19
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212982/
https://www.ncbi.nlm.nih.gov/pubmed/35757456
http://dx.doi.org/10.1016/j.ensci.2022.100411
work_keys_str_mv AT motahharyniaali abruptbilateralblindnessasararepostacutedemyelinatingconsequenceofcovid19
AT naghavisaba abruptbilateralblindnessasararepostacutedemyelinatingconsequenceofcovid19
AT shaygannejadvahid abruptbilateralblindnessasararepostacutedemyelinatingconsequenceofcovid19
AT adibiiman abruptbilateralblindnessasararepostacutedemyelinatingconsequenceofcovid19